Condensed Consolidated Statements of Operations - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Jun. 30, 2023 |
Jun. 30, 2022 |
Jun. 30, 2023 |
Jun. 30, 2022 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Defined Benefit Plan Disclosure [Line Items] | ||||||
| Product revenues, net | $ 5,830 | $ 4,441 | $ 14,544 | $ 14,177 | $ 28,541 | $ 24,043 |
| Revenues, related party | 18 | 16 | 36 | 31 | 133 | 57 |
| Total revenues, net | 5,848 | 4,457 | 14,580 | 14,208 | 28,674 | 24,100 |
| Operating expenses | ||||||
| Research and development | 11 | 11 | 733 | 697 | ||
| Restructuring costs | 752 | |||||
| Change in fair value of contingent consideration | 100 | (1,900) | (100) | (1,900) | (3,800) | (1,402) |
| Total operating expenses | 14,547 | 10,669 | 28,770 | 23,530 | 47,255 | 49,301 |
| Loss from operations | (8,699) | (6,212) | (14,190) | (9,322) | (18,581) | (25,201) |
| Other income (expense) | ||||||
| Change in fair value of warrants | 375 | 5,371 | 1,403 | 14,082 | 19,017 | (12,801) |
| Warrant inducement expense | (2,629) | |||||
| Change in fair value of investment, related party | (1,482) | (4,424) | 1,747 | |||
| Interest expense, net | (79) | (38) | (114) | (71) | (195) | (344) |
| Other income, net | 62 | 29 | 30 | 52 | 33 | 689 |
| Total other income (expense) | (1,124) | 5,362 | (3,105) | 14,063 | 17,973 | (12,456) |
| Income (loss) before income taxes | (9,823) | (850) | (17,295) | 4,741 | (608) | (37,657) |
| Income tax expense | 14 | 20 | 30 | 32 | 56 | |
| Net income (loss) | $ (9,837) | $ (850) | $ (17,315) | $ 4,711 | $ (640) | $ (37,713) |
| Income (loss) per common share: | ||||||
| Basic | $ (7.23) | $ (0.90) | $ (12.73) | $ 5.24 | $ (0.61) | $ (85.63) |
| Diluted | $ (7.23) | $ (0.90) | $ (12.73) | $ 5.22 | $ (0.61) | $ (85.63) |
| Weighted-average common shares outstanding: | ||||||
| Basic | 1,360,739 | 941,175 | 1,359,894 | 898,444 | 1,056,988 | 440,412 |
| Diluted | 1,360,739 | 941,175 | 1,359,894 | 902,209 | 1,056,988 | 440,412 |
| Related Party [Member] | ||||||
| Operating expenses | ||||||
| Cost of revenues | $ 2,772 | $ 2,402 | $ 7,319 | $ 7,377 | $ 14,618 | $ 12,222 |
| Selling, general and administrative | 92 | 346 | 119 | 441 | 733 | 697 |
| Nonrelated Party [Member] | ||||||
| Operating expenses | ||||||
| Cost of revenues | 116 | 152 | 167 | 327 | 567 | 520 |
| Selling, general and administrative | $ 11,456 | $ 9,669 | $ 21,254 | $ 17,285 | $ 35,137 | $ 36,512 |
| X | ||||||||||
- Definition Revenue from related party. No definition available.
|
| X | ||||||||||
- Definition Warrant inducement cost experience. No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) on investment. Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The net amount of operating interest income (expense). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount included in cost of sales related to transactions with related parties incurred and recorded in the statement of operations for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|